Crizotinib and Cobicistat: Interaction Details

Brand names
Cobicistat
Tybost
Crizotinib
Xalkori
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

What Happens When You Take Crizotinib With Cobicistat

What can happen when they are taken together (rated Contraindicated)

Increased crizotinib exposure and an increased cobicistat exposure

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Cobicistat should not be given together with drugs that rely heavily on for their and whose raised could cause serious or life-threatening reactions, and crizotinib falls into this group, so the combination is .2 In addition, crizotinib inhibits , and cobicistat is a drug that is mainly by CYP3A4, so using them together may lead to higher cobicistat exposure.

When the combination cannot be avoided, crizotinib must be given at a reduced dose. For patients with NSCLC or IMT, the crizotinib dose should be lowered to 250 mg once daily, and crizotinib should be stopped permanently if 250 mg once daily is not tolerated.

For pediatric patients with ALCL or IMT, and for young adults with ALCL, the reduced dose depends on BSA: 1.7 m(2) or greater, 250 mg twice daily; 1.17 to 1.69 m(2), 200 mg twice daily; 0.98 to 1.16 m(2), 170 mg once daily; 0.81 to 0.97 m(2), 150 mg once daily; 0.62 to 0.80 m(2), 120 mg once daily; 0.52 to 0.61 m(2), 90 mg once daily; 0.47 to 0.51 m(2), 80 mg once daily; 0.38 to 0.46 m(2), 70 mg once daily. After cobicistat has been discontinued, crizotinib can be returned to the dose used before the interaction.1

The Crizotinib and Cobicistat Interaction, Explained

Both medicines can raise each other's levels in your body. Cobicistat (Tybost) is a booster that slows an enzyme called , and crizotinib (Xalkori) is a cancer medicine that is cleared by that same enzyme. Taken together, crizotinib can build up, which may mean more side effects such as nausea, vision changes, liver problems, or heart rhythm changes. Crizotinib can also slightly raise cobicistat levels.

This combination is normally avoided. This is based on how the drugs work rather than on large studies. If both are truly needed, your care team can adjust the crizotinib dose and watch you more closely. Please keep taking your medicines as prescribed and talk with your pharmacist or doctor before changing anything.

(labeling-based; evidence theoretical). Cobicistat is a strong mechanism-based . Crizotinib is a and a moderate CYP3A inhibitor, so crizotinib exposure (, ) is expected to rise, and cobicistat exposure may rise via reciprocal CYP3A4 . Onset is unspecified.

  • Risks of higher crizotinib exposure: , , , ILD/pneumonitis, visual disturbances, effects.
  • Preferred: avoid the combination or choose an alternative.
  • If unavoidable, reduce crizotinib: NSCLC/IMT 250 mg once daily; permanently discontinue if not tolerated. Pediatric ALCL/IMT and young adult ALCL doses are BSA-based (from 250 mg BID at BSA 1.7 m² or more down to 70 mg daily at 0.38 to 0.46 m²).
  • Monitor closely (LFTs, , heart rate, toxicity). Resume the prior crizotinib dose after cobicistat is stopped.

See the 2 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Crizotinib and Cobicistat Interact

The likely mechanism

of -mediated crizotinib by cobicistat; inhibition of CYP3A4-mediated cobicistat metabolism by crizotinib

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Crizotinib and Cobicistat Interaction

Your care team will usually try to avoid this pair. If both are needed, they can lower your crizotinib dose and monitor you more closely for side effects.

  • Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise.
  • Ask your pharmacist or doctor whether your crizotinib dose should be adjusted, since the right dose depends on your condition and, for children and young adults, body size.
  • Report new symptoms promptly, such as vision changes, dizziness, a slow or irregular heartbeat, yellowing of the skin or eyes, or trouble breathing.
  • If cobicistat is stopped, your team will tell you when to return to your usual crizotinib dose.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Crizotinib or Cobicistat need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

3 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: XALKORI oral pellets, oral capsules, crizotinib oral pellets, oral capsules

    In a study, crizotinib 250 mg twice daily for 28 days (a ) was given together with oral midazolam (a CYP3A ), and the geometric mean midazolam rose 3.7-fold relative to midazolam given alone.1

  2. Report 2 · Study title

    Prescribing information: XALKORI oral pellets, oral capsules, crizotinib oral pellets, oral capsules

    When ketoconazole 200 mg twice daily, a strong , was coadministered with a single 150-mg dose of crizotinib (a CYP3A ), the and of crizotinib increased by 216% and 44%, respectively.1

  3. Report 3 · Study title

    Prescribing information: XALKORI oral pellets, oral capsules, crizotinib oral pellets, oral capsules

    When itraconazole 200 mg once daily, a strong , was given with crizotinib 250 mg once daily (a CYP3A ), the steady-state and of crizotinib were raised by 57% and 33%, respectively.1

Crizotinib and Cobicistat: Common Questions

How serious is the Crizotinib and Cobicistat interaction?

It is rated . These should generally not be used together.

How is the Crizotinib and Cobicistat interaction managed?

Your care team will usually try to avoid this pair. If both are needed, they can lower your crizotinib dose and monitor you more closely for side effects. Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Ask your pharmacist or doctor whether your crizotinib dose should be adjusted, since the right dose depends on your condition and, for children and youn… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Crizotinib and Cobicistat Interaction

Ask in your own words about taking Crizotinib and Cobicistat together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (2)

  1. Product Information: XALKORI(R) oral pellets, oral capsules, crizotinib oral pellets, oral capsules. Pfizer Labs (per FDA), New York, NY, 2023. DailyMed
  2. Product Information: STRIBILD(TM) oral tablets, elvitegravir cobicistat emtricitabine tenofovir disoproxil fumarate oral tablets. Gilead Sciences, Inc. (per manufacturer), Foster City, CA, 2012. DailyMed
Was this write-up helpful?

Other Serious Interactions of Crizotinib and Cobicistat

Also serious with Cobicistat

Also serious with Crizotinib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Cobicistat

With Crizotinib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together. This interaction.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.